We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis.
- Authors
Ikeda-Iwabu, Yuka; Taniyama, Yoshiaki; Katsuragi, Naruto; Sanada, Fumihiro; Koibuchi, Nobutaka; Shibata, Kana; Shimazu, Kenzo; Rakugi, Hiromi; Morishita, Ryuichi; Aqeilan, Rami; Yun, Chae-OK
- Abstract
Background: Periostin (POSTN) is a 93 kDa matrix protein that helps to regulate collagen gene expression in the extracellular matrix. POSTN overexpression is a prognostic factor in malignant cancers; however, some researchers have observed it in the stroma, whereas others have reported it on tumors. Objective: This study aimed to investigate the function of POSTN on tumors. Methods and Results: We found that POSTN in cancer cells can be detected by using an antibody against the POSTN C-terminal region exon 17 (Ex17 antibody), but not with an antibody against the POSTN N-terminal region exon 12 (Ex12 antibody) in patients with breast cancer. In a fraction secreted from fibroblasts, LC–MS/MS analysis revealed a short fragment of POSTN of approximately 40 kDa with exon 17. In addition, molecular interaction analysis showed that POSTN with exon 17, but not POSTN without exon 17, bound specifically to wnt3a, and the Ex17 antibody inhibited the binding. Conclusion: A short fragment of POSTN with exon 17, which originates in the fibroblasts, is transported to cancer cells, whereas POSTN fragments without exon 17 are retained in the stroma. The Ex17 antibody inhibits the binding between POSTN exon 17 and wnt3a.
- Subjects
METASTATIC breast cancer; PERIOSTIN; MOLECULAR interactions; BREAST cancer; CANCER prognosis; EXTRACELLULAR matrix proteins
- Publication
Cells (2073-4409), 2021, Vol 10, Issue 4, p892
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells10040892